Skip to main content

RENAISSANCE TECHNOLOGIES LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1037389 NEW YORK, NY

Position in NBIX

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$318,665,490
+$1,136,912 QoQ
Shares Held
2,418,897
+8.0% QoQ
Ownership
2.41%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

RENAISSANCE TECHNOLOGIES LLC holds $2,196,847,717 across 49 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (14.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
2,418,897 $318,665,490

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $318,665,490 2,418,897
2025-12-31 $317,528,578 2,238,797
2025-09-30 $339,480,532 2,418,297
2025-06-30 $297,432,438 2,366,397
2025-03-31 $276,798,288 2,502,697
2024-12-31 $339,802,690 2,489,397
2024-09-30 $296,639,190 2,574,546
2024-06-30 $339,789,659 2,468,146
2024-03-31 $310,547,016 2,251,646
2023-12-31 $262,010,820 1,988,546
2023-09-30 $178,893,450 1,590,164
2023-06-30 $154,972,808 1,643,402
2023-03-31 $197,081,818 1,947,064
2022-12-31 $192,736,028 1,613,664
2022-09-30 $153,204,101 1,442,464
2022-06-30 $141,250,762 1,449,023
2022-03-31 $120,011,531 1,280,123
2021-12-31 $121,253,462 1,423,664
2021-09-30 $130,050,507 1,355,964
2021-06-30 $120,941,802 1,242,723
2021-03-31 $135,942,274 1,397,864
2020-12-31 $173,219,257 1,807,191
2020-09-30 $206,692,458 2,149,464
2020-06-30 $181,141,208 1,484,764
2020-03-31 $62,262,512 719,382